| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 201 | FEED COMPOSITION AND PRODUCTION METHOD FOR SAME | EP13819848.6 | 2013-07-16 | EP2875735A1 | 2015-05-27 | YAMAMOTO, Masahiro |
Provided are a feed composition, which can be stored for a long time and is easily produced and adjustable in components, and which can increase the body weight and reduce a feed conversion ratio of farm animals to which the feed composition is fed, and a production method for the feed composition. In the feed composition, a liquid feed additive obtained by fermenting a carbohydrate-containing carbohydrate raw material by Aspergillus is substituted for 5 to 50% on a dry matter basis of a feed raw-material. |
||||||
| 202 | ARRAY OF COMPLEMENTARY INFANT/YOUNG CHILD NUTRITIONAL COMPOSITIONS | EP11779602.9 | 2011-10-25 | EP2640202A1 | 2013-09-25 | KLASSEN, Petra; MAGLIOLA, Corinne |
| The present invention relates to infant/young child nutrition. A set of nutritional compositions having beneficial effects to infants/young children is disclosed. The set of nutritional compositions comprises at least two compositions with varying amounts of components which impart a beneficial effect to the infants young/children. A nutrition kit for infants/young children comprising the set of nutritional compositions is also disclosed as well as a method for manufacturing the set of nutritional components. A dosage regimen is also disclosed. | ||||||
| 203 | Lactobacillus fermentum CECT 7472 strain with probiotic properties | EP11382132.6 | 2011-05-06 | EP2520644A1 | 2012-11-07 | Lasserrot Cuadrado, Agustín; Ruiz Løpez, Maria Dolores; Ruiz Bravo Løpez, Alfonso |
The invention relates to a Lactobacillus fermentum strain with probiotic properties and enhanced activity against enteropathogens. The strain is Lactobacillus fermentum CECT 7472, which may be used as an ingredient in edible products, while maintaining its beneficial gastrointestinal health properties. |
||||||
| 204 | MIXTURE OF LACTIC ACID BACTERIA FOR THE PREPARATION OF GLUTEN FREE BAKED PRODUCTS | EP07805691.8 | 2007-07-03 | EP2046944B1 | 2012-09-19 | GIULIANI, Giammaria; BENEDUSI, Anna; DI CAGNO, Raffaella; DE ANGELIS, Maria; LUISI, Antonella; GOBBETTI, Marco |
| 205 | ZUSAMMENSETZUNG MIT STÄMMEN VON LACTOBAZILLUS FERMENTUM | EP10763304.2 | 2010-08-11 | EP2464361A2 | 2012-06-20 | Schrezenmeir, Jürgen; Heller, Knut J. |
| The invention relates to a pharmaceutical and/or dietetic composition for increasing the impact of the immune defense of higher living beings, wherein bacteria of the species Lactobacillus fermentum from at least one of the strains K1-Lb1 or K1-Lb6 or K2-Lb4 or K6-Lb4 or K7-Lb1 or K8-Lb1 or K9-Lb6 are contained in order to control the adaptive and natural immune defense by means of T helper 1 and T helper 2 cells and/or bacteria of the species Lactobacillus fermentum from at least one of the strains K2-Lb6 or K11-Lb3 are contained in order to strengthen the native immune defense. | ||||||
| 206 | A METHOD FOR PRODUCING A FERMENTED MILK PRODUCT | EP10727741.0 | 2010-06-30 | EP2448420A2 | 2012-05-09 | FOLKENBERG, Ditte Marie; POULSEN, Lone |
| The present invention relates to a method for producing a fermented milk product with eithanced gel stiffness, wherein a polysaccharide producing Lactobacillus, in particular L. johnsonii, is used as starter. | ||||||
| 207 | COMPOSITION FOR PREVENTING OR TREATING ARTRITIS COMPRISING LACTIC ACID BACTERIA AND COLLANGEN AS ACTIVE INGREDIENTS | EP06798857.6 | 2006-09-22 | EP1945234A1 | 2008-07-23 | IM, Sin Hyeog; SO, Jae Seon; YI, Hwa Joong |
| The present invention relates to a composition for preventing or treating arthritis, which comprises a lactic acid bacterium and collagen as major active ingredients. The present composition shows excellent prevention or treatment efficacies on arthritis of animal models. In addition, since the active ingredients used in the composition of this invention have been recognized to be safe to human, the present composition has considerable safety with enhanced immunomodulatory effect in patients with arthritis. | ||||||
| 208 | LACTOBACILLUS FERMENTUM STRAIN AND USES THEREOF | EP03720781.8 | 2003-04-02 | EP1608737A1 | 2005-12-28 | SERVIN, Alain; CHAUVIERE, Gilles; POLTER, Marie-Hélène; LE MOAL, Vanessa; GASTEBOIS, Bruno |
| The present invention concerns a new strain of Lactobacillus fermentum (LB-f) that is useful in preventing or treating gastrointestinal disorders in mammals, especially in humans. Also, this strain can be used as a dietary product that is beneficial to the wellbeing and health of mammals, including humans. | ||||||
| 209 | PROBIOTIC BACTERIUM: LACTOBACILLUS FERMENTUM | EP03793503.8 | 2003-09-08 | EP1539927A1 | 2005-06-15 | CONWAY, Paricia, Lynne |
| Variant of the bacterium Lactobacillus fermentum and its use in treating gastrointestinal disorders, disorders of the mucosal surfaces or disturbances in the immune system or status of a subject. | ||||||
| 210 | COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS | EP03739405.3 | 2003-02-17 | EP1482959A1 | 2004-12-08 | CONWAY, Patricia, Lynne; COLLIER, Paul, Anthony |
| The present invention concerns methods and compositions for prophylactic or therapeutic treatment of skin disorders by administering therapeutically or prophylactically effective amounts of a probiotic. The present invention is also concerned with the treatment of symptoms of skin disorders. | ||||||
| 211 | FERMENTED SOYA BASED MIXTURE COMPRISING ISOFLAVONES- AGLICONES, EQUOL AND LUNASIL, PROCESS FOR THE PREPARATION AND USES THEREOF IN FOOD, MEDICAL AND COSMETIC FIELDS | PCT/IT2011000240 | 2011-07-11 | WO2012007978A3 | 2012-05-18 | GIULIANI GIAMMARIA; BENEDUSI ANNA; GOBBETTI MARCO; DI CAGNO RAFFAELLA; BARONI SERGIO; RIZZELLO CARLO GIUSEPPE |
| The present invention concerns a mixture comprising isoflavones-aglicones, such as daidzein, genistein and glycitein, in addition to equol and lunasin, said mixture being based on soya fermented using lactic acid bacteria isolated from food matrices and use of said mixture for protection of skin and similar and of human intestinal cells with particular reference to prevention of inflammatory state and protection of barrier functions and hair loss treatment. | ||||||
| 212 | A METHOD FOR PRODUCING A FERMENTED MILK PRODUCT | PCT/EP2010059303 | 2010-06-30 | WO2011000879A3 | 2011-05-05 | FOLKENBERG DITTE MARIE; POULSEN LONE |
| The present invention relates to a method for producing a fermented milk product with enhanced gel stiffness, wherein a polysaccharide producing Lactobacillus, in particular L. johnsonii, is used as starter. | ||||||
| 213 | COMPOSITIONS AND METHODS OF USE OF NOVEL STRAINS OF LACTOBACILLUS FERMENTUM | EP16880154.6 | 2016-12-23 | EP3393484A1 | 2018-10-31 | VALLEJO GALLAND, Belinda; GONZÁLEZ CÓRDOVA, Aarón Fernando; FEREGRINO QUEZADA, José Antonio; FEREGRINO QUEZADA, Juan, Carlos |
| Provided herein are novel Lactobacillus fermentum strains, NRRL B-67059 or NRRL B-67060, compositions containing the NRRL B-67059 or NRRL B-67060 strains, and fermented dairy products and bioactive compounds prepared using the NRRL B-67059 or NRRL B-67060 strains. Also provided are methods of modulating the immune system of a subject. | ||||||
| 214 | FERMENTATION | EP16805225.6 | 2016-11-04 | EP3371293A1 | 2018-09-12 | GIUSEPPIN, Marco Luigi Federico; MOOIJ, Catharina Maria Antoinette; SPELBRINK, Robin Eric Jacobus |
| It has been found that addition of potato protein protease inhibitor to a fermentation feed significantly reduces the lag time of the fermentation. The required amount of potato protein is low enough not to affect the taste of the target substance adversely, and the lag time reduction occurs both in batch- and in semi-continuous processes. The invention further pertains to a fermented food product which is not yogurt, comprising potato protein protease inhibitor. | ||||||
| 215 | FEED COMPOSITION AND PRODUCTION METHOD FOR SAME | EP13819848.6 | 2013-07-16 | EP2875735B1 | 2018-03-21 | YAMAMOTO, Masahiro |
| Provided are a feed composition, which can be stored for a long time and is easily produced and adjustable in components, and which can increase the body weight and reduce a feed conversion ratio of farm animals to which the feed composition is fed, and a production method for the feed composition. In the feed composition, a liquid feed additive obtained by fermenting a carbohydrate-containing carbohydrate raw material by Aspergillus is substituted for 5 to 50% on a dry matter basis of a feed raw-material. | ||||||
| 216 | ZUSAMMENSETZUNG MIT STÄMMEN VON LACTOBAZILLUS FERMENTUM ZUR VERWENDUNG ZUR VERSTÄRKUNG DER IMMUNABWEHR | EP10763304.2 | 2010-08-11 | EP2464361B1 | 2018-01-17 | Schrezenmeir, Jürgen; Heller, Knut J. |
| 217 | DRYING LACTIC ACID BACTERIA AND COMPOSITIONS | EP12730974.8 | 2012-06-30 | EP2726597B1 | 2017-11-15 | YDE, Birgitte; SVENDSEN, Jakob, Blenker |
| 218 | FERMENTED SOY-BASED MIXTURE COMPRISING ISOFLAVONES-AGLYCONES, EQUOL AND LUNASIL, PROCESS FOR THE PREPARATION AND USES THEREOF IN FOOD, MEDICAL AND COSMETIC FIELDS | EP11754750.5 | 2011-07-11 | EP2593570B1 | 2017-03-01 | GIULIANI, Giammaria; BENEDUSI, Anna; GOBBETTI, Marco; DI CAGNO, Raffaella; BARONI, Sergio; RIZZELLO, Carlo Giuseppe |
| 219 | COMPOSITION COMPRISING LACTOBACILLUS AND A CARRIER | EP14702635.5 | 2014-02-05 | EP2953476A1 | 2015-12-16 | ROBINS, Karen Tracey; MAZOTTI, Judith; GASSER, Kurt |
| Subject of the invention is a food composition comprising Lactobacillus, or a Lactobacillus preparation, which comprises Lactobacillus cell walls, cell wall fragments and/or cell wall constituents, which is capable of aggregating Helicobacter pylori under physiological conditions, and a carrier, wherein the carrier comprises skim milk. Subject of the invention are also methods for producing such food compositions and uses thereof. | ||||||
| 220 | METHOD OF TREATMENT USING LACTOBACILLUS FERMENTUM ME-3 | EP13824661.6 | 2013-12-20 | EP2943210A1 | 2015-11-18 | KULLISAAR, Tiiu; ZILMER, Mihkel; SMIDT, Imbi; ZILMER, Kersti; MIKELSAAR, Marika; HÜTT, Pirje |
| The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component, a metabolic syndrome related disorder selected from prediabetes, type 2 diabetes and cardiovascular disease. The effect may be achieved by simultaneously: decreasing the level of glycated haemoglobin HbA1c, decreasing or preventing low-grade inflammation on a cellular level and increasing the level of adiponectin. | ||||||
QQ群二维码
意见反馈
意见反馈